Related Experiment Video
Updated: May 3, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
Continuing improvement in type 2 diabetes care through performance-based evaluations
Howard B A Baum1, Enrico Cagliero, Carolyn A Berry
1University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Journal of Primary Care & Community Health
|January 24, 2014
Summary
This study shows that a continuing medical education (CME) performance improvement (PI) activity enhanced clinician adherence to type 2 diabetes mellitus (T2DM) guidelines. This led to better patient outcomes, including improved glycemic control and reduced cardiovascular risk factors.
Area of Science:
- Endocrinology
- Medical Education
- Quality Improvement
Background:
- Type 2 Diabetes Mellitus (T2DM) management requires timely, evidence-based care to control glycemic levels and prevent complications.
- Performance Improvement (PI) activities are crucial for enhancing adherence to clinical guidelines in T2DM care.
Purpose of the Study:
- To implement a CME-certified PI activity to improve clinician adherence to T2DM evidence-based recommendations.
- To assess the impact of the PI activity on clinician performance and patient outcomes.
Main Methods:
- A 3-stage process involving self-assessment, goal setting, and reassessment was used.
- 64 clinicians participated, abstracting data from 1600 patient charts before and after the intervention.
Main Results:
- Clinicians increased patient assessment for complications and counseling on nutrition, exercise, and smoking cessation.
- Treatment modifications were more likely for patients with uncontrolled A1C, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C).
- Significant improvements were observed: mean A1C decreased (7.5% to 7.3%), BP ≥130/80 mm Hg decreased (37% to 30%), and LDL-C >100 g/dL decreased (33% to 27%).
Conclusions:
- The PI CME activity successfully improved clinician performance in key quality measures for T2DM care.
- Enhanced adherence to evidence-based guidelines resulted in significant positive changes in patient outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17